Weight loss drug Mounjaro launched in India: Know price, how it works, side-effects, and if it’s more effective than Ozempic
The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ingredient in Wegovy and Ozempic) will go off-patent in India, allowing local firms to introduce cheaper alternatives.
In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene therapy for hemophilia priced at $3.5 million per patient. Bluebird Bio, a ...
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Protein has received widespread attention for weight loss thanks to its powerful role in building and maintaining ...
He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...
Mounjaro, an injectable medication designed to support weight loss, works by imitating the effects of two natural hormones, ...
South China Morning Post on MSN2h
Why Ozempic and other weight-loss drugs are changing the face of snackingPeople are buying healthier snacks and household food bills are dropping as GLP-1 weight-loss drugs alter eating habits.
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
Megan Stalter, who portrays Kayla in the Max drama "Hacks," slammed those who lie about taking Ozempic for weight-loss ...
Most people know that using weight loss medication can throw up all sorts of side effects - some more sinister than others - ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback